Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Income from Non-Controlling Interests (2016 - 2019)

Lisata Therapeutics (LSTA) has disclosed Income from Non-Controlling Interests for 9 consecutive years, with -$1000.0 as the latest value for Q2 2018.

  • For the quarter ending Q2 2018, Income from Non-Controlling Interests rose 99.5% year-over-year to -$1000.0, compared with a TTM value of -$1000.0 through Sep 2023, changed N/A, and an annual FY2020 reading of $9000.0, changed 0.0% over the prior year.
  • Income from Non-Controlling Interests was -$1000.0 for Q2 2018 at Lisata Therapeutics, up from -$2000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $386156.0 in Q4 2017 and bottomed at -$405072.0 in Q3 2016.
  • Average Income from Non-Controlling Interests over 5 years is -$89693.1, with a median of -$66879.0 recorded in 2016.
  • The sharpest move saw Income from Non-Controlling Interests plummeted 2295.88% in 2016, then skyrocketed 429.11% in 2017.
  • Year by year, Income from Non-Controlling Interests stood at -$78436.0 in 2014, then soared by 78.44% to -$16907.0 in 2015, then crashed by 593.98% to -$117332.0 in 2016, then surged by 429.11% to $386156.0 in 2017, then crashed by 100.26% to -$1000.0 in 2018.
  • Business Quant data shows Income from Non-Controlling Interests for LSTA at -$1000.0 in Q2 2018, -$2000.0 in Q1 2018, and $386156.0 in Q4 2017.